Here are relevant reports on : point-of-care-diagnostics-market
-
ASEAN Point of Care Diagnostics Market by Product (Infectious Disease (TB, Hepatitis, STDs, HAIs), Glucose, Cardiometabolic, Pregnancy, Coagulation), Technology (Lateral Flow Assays, Biochemistry, MDx), End User (Home Care, Hospitals) - Forecast to 2030
Global ASEAN point of care diagnostics market valued at $1.05B in 2024, reached $1.08B in 2025, and is projected to grow at a robust 4.7% CAGR, hitting $1.36B by 2030. The increasing incidence of chronic conditions, especially diabetes, generates the demand for regular monitoring and early detection, boosting the need for rapid & accurate POC testing solutions
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Top 10 Medical Devices Market – (Point of Care Diagnostics, Hemodialysis, Minimally Invasive Surgery, Cataract & Ocular Lens, Patient Monitors) – Global Trends, Developments and Forecasts up till 2015
The global top 10 medical devices market was expected to be worth $164 billion in the year 2010 and is estimated to reach $228 billion by 2015, growing at a CAGR of 6.8% from 2010 to 2015. The cardiovascular devices, orthopedic devices, and diagnostic imaging devices markets are the major revenue generators for the medical devices industry
- Published: June 2011
- Price: $ 4950
- TOC Available:
-
US Point of Care Diagnostics Market by Product [Glucose, Infectious Disease (TB, HAI, STD), Pregnancy], Purchase Mode (Rx, OTC), Technology [Biochemistry, MDx (RT-PCR, INAAT)], Sample (Blood, Urine), End User (Home Care, Hospitals) - Forecast to 2031
The US Point of Care Diagnostics market, valued at US$6.4 billion in 2025, stood at US$6.8 billion in 2026 and is projected to advance at a resilient CAGR of 9.2% from 2026 to 2031, culminating in a forecasted valuation of US$10.6 billion by the end of the period. The primary factor driving the growth of the US point of care diagnostics market is the increasing demand for fast and reliable testing solutions to address the rising incidence of lifestyle and infectious diseases.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Latin America Point of Care Diagnostics Market by Product (Glucose, Infectious Disease [TB, HAI, STD], Pregnancy), Purchase Mode (Rx, OTC), Technology (Biochemistry, MDx [RT-PCR, INAAT]), Sample (Blood, Urine), End User (Home Care, Hospitals) - Forecast to 2031
The Latin America point-of-care diagnostics market, valued at US$0.75 billion in 2025, stood at US$0.79 billion in 2026 and is projected to advance at a resilient CAGR of 7.9% from 2026 to 2031, culminating in a forecasted valuation of US$1.15 billion by the end of the period. This growth is driven by the increasing demand for diagnostic solutions to address the rising burden of chronic and infectious diseases. Key factors contributing to this expansion include improvements in healthcare infrastructure, increased public and private investments in decentralized testing, and greater access to near-patient diagnostic technologies.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Point of Care Diagnostics Market by Product (Glucose, Infectious Disease [TB, HAI, STD], Pregnancy), Purchase Mode (Rx, OTC), Technology (Biochemistry, MDx [RT-PCR, INAAT]), Sample (Blood, Urine), End User (Home Care, Hospitals) - Global Forecast to 2031
The global point of care diagnostics market is projected to reach USD 31.46 billion by 2031, growing at a CAGR of 8.8% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Europe Point of Care Diagnostics Market by Product [Glucose, Infectious Disease (TB, HAI, STD), Pregnancy], Purchase Mode (Rx, OTC), Technology [Biochemistry, MDx (RT-PCR, INAAT)], Sample (Blood, Urine), End User (Home Care, Hospitals) - Forecast to 2031
The Europe point-of-care testing market, valued at USD4.14 billion in 2025, stood at USD4.45 billion in 2026 and is projected to advance at a resilient CAGR of 10.0% from 2026 to 2031, culminating in a forecasted valuation of USD7.17 billion by the end of the period. The Europe point-of-care diagnostics market is being fueled by a number of key drivers, including the increasing trend towards decentralized and community-based healthcare practices and the increasing demand for rapid clinical decision-making at or near the point of patient care.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Transcutaneous Monitors Market by Type (Adult Wound Healing, Neonatal Care), Application (Sleep Diagnostics, Respiratory Care, Plastic surgery) & End User (Hospitals, Speciality Clinic, Neonatal Intensive Care, Diagnostic Center) - Global Forecast to 2023
The global transcutaneous monitors market is expected to reach USD 206.9 million by 2023 from USD 154.6 million in 2018, growing at a CAGR of 6.0%. Increasing demand for non-invasive monitoring; rising risk of respiratory diseases; increasing healthcare expenditure in developing economies such as India, China, Brazil; and technological advancement leading to more accuracy are some of the major factors driving the growth of the global transcutaneous monitors market. These driving factors consequence to the rapid adoption of these new devices, thus propelling the market growth.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Hospital Filtration Market by Type (Point of Use Filters, Inline Filters, Standalone Filtration Units, Disposable Filters), Process Type, Application (Hospital Facilities, Laboratories, Patient Care Equipment) and Region - Global Forecast to 2030
The hospital filtration market is expected to grow from USD 2.10 billion in 2024 to USD 3.19 billion by 2030, at a CAGR of 7.2% during the forecast period. To enable an in-depth understanding of the competitive landscape, the report includes the profiles of some of the top players in the hospital filtration market. These includes Danaher (US), Veolia (France), Pentair (US), Merck KgaA (Germany), Daikin Industries (Japan), Camfil (Sweden), Freudenberg Technologies (Germany), Solventum (US), Sartorius AG (Germany), and Parker Hannifin Corp. (US)
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
CT/NG Testing Market by Product (Assays, Kits & Analyzers), Test Type (Laboratory, Point-of-care Testing), Technology (INAAT, PCR, Immunodiagnostics), End User (Diagnostic Labs, Hospitals & Clinics) & Region - Global Forecast to 2028
The global CT/NG testing market, valued at US$1.6 billion in 2022, stood at US$1.7 billion in 2023 and is projected to advance at a resilient CAGR of 8.6% from 2023 to 2028, culminating in a forecasted valuation of US$2.7 billion by the end of the period. Market growth is largely driven by the increasing prevalence of CT/NG infections and the growing investments and funding for R&D in CT/NG diagnosis.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
North America Blood Glucose Monitoring Devices Market by Product Type (Self-monitoring, Professional Point of Care), Application (Diabetes Management, Health & Wellness Monitoring), Test Site, End User (Self/Homecare) - Forecast to 2030
The North America Blood Glucose Monitoring Devices market, valued at USD 6.02 billion in 2024, stood at USD 6.52 billion in 2025 and is projected to advance at a resilient CAGR of 8.8% from 2025 to 2030, culminating in a forecasted valuation of USD 9.93 billion by the end of the period. The North America blood glucose monitoring devices market is experiencing steady growth, driven by several key factors. Rising diabetes prevalence, fueled by aging populations, urbanization, and lifestyle changes, is increasing demand for effective self-monitoring solutions.
- Published: October 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
